One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Nebulizers Market
Nebulizers Market
Nebulizers Market
Published date: Nov 2021 •Formats:
Request Sample Schedule a Call
  • Home » Nebulizers Market

Global Nebulizers Market By Type (Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers), By Application (COPD, Cystic fibrosis, and Asthma), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022–2032

  • Published date: Nov 2021
  • Report ID: 16513
  • Number of Pages: 284
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Nebulizers Market Overview:

    The global nebulizer market was worth USD 1,100 million in 2021. It is projected to grow at a 7.3% CAGR from 2022 to 2032.

    This high growth can be attributed to rising rates of chronic respiratory diseases, rising demand for home health devices, as well as the growing geriatric population. According to the Centers for Disease Control and Prevention (CDC), Chronic Obstructive Pulmonary Disease is the fourth leading cause of death in the U.S.

    Global Nebulizer Market Scope:

    Type Analysis

    The low cost of jet nebulizers made them the most popular in terms of revenue which is 64%. Jet nebulizers have been the most popular segment for years due to their ease of use and effective design for drug delivery. Jet nebulizers can deliver formulations that are not possible to be delivered using dry powder inhalers or pressurized metered-dose inhalers.

    There are many options for nebulizers: they come in a variety of designs, including jet nebulizers and corrugated tubes, collection bags, and breath-enhanced or breath-actuated jet nebulizers.

    Because of their technologically advanced compact devices and minimal drug loss, the mesh nebulizers market is expected to grow significantly over the forecast period.

    Mesh nebulizers are expected to continue growing, mainly due to patient acceptance, ease of use, portability, convenience, and quick treatment. Market penetration is also being aided by the increasing acceptance of mesh-nebulizers because they deliver drugs to the lungs accurately and have lower residual volumes.

    nebulizer market 2

    End-Use Analysis

    Hospitals and clinics accounted for 64.8% of the total revenue in 2021. This is due to favorable reimbursement policies and higher patient footfall. Hospitals are an integral part of the healthcare industry and provide the industry’s largest revenue source.

    Multiple companies spend significant efforts to promote their products/services in hospitals.

    Cipla Limited announced in 2021 a plan to increase access to nebulization therapy in rural India for acute asthma management. These projects help to boost segment growth.

    In recent years, home healthcare devices have gained popularity and market share. The adoption of home healthcare devices is increasing due to technological advances and the minimization of product sizes.

    Home healthcare devices will be driven by the increasing geriatric population, rising incidence of target diseases, and the need to reduce healthcare spending.

    The market is expected to grow because home healthcare is an affordable alternative to costly hospital stays.

    Home healthcare is becoming more popular due to the availability of small nebulizers, which are easy to use. Technological innovations in nebulizers are also increasing their popularity.

    Key Market Segments:

    By Type

    •  Jet
    •  Mesh
    •  Ultrasonic

    By End-Use

    •  Hospitals & Clinics
    •  Emergency Centers
    •  Home Healthcare

    Market Dynamics:

    The rising prevalence of respiratory disease in North America is also due to the increased consumption of alcohol, cigarettes, as well as ultra-processed beverages such as sugar-sweetened drinks. The Centers for Disease Control and Prevention data show that tobacco use is responsible for approximately 13% of all deaths among adults between 30 and 70 in North America.

    The demand for nebulizers will rise as a result of increased smoking and environmental pollution. According to the WHO, there were 323 million COPD-related deaths in 2019.

    Initiatives such as the “Global Alliance against Chronic Respiratory Diseases,” which aims to improve the diagnosis and treatment of respiratory disorders, may drive the market for nasal nebulizers.

    Millions of people have been affected by the COVID-19 pandemic. The global pandemic forced healthcare professionals to rush to find preventive and therapeutic solutions.

    Patients with COPD or asthma who knew about the possibility of COVID-19 being airborne were cautious about using an inhaled medication, as they are potentially a source of virus transmission and immunosuppression.

    All patients with COPD or asthma were advised by medical professionals to continue taking their prescribed inhaled medications. When albuterol inhalers were in short supply, nebulized albuterol was offered as an alternative.
    Many pharmaceutical companies are also focusing their efforts on the development of effective COVID-19 treatments. These will primarily be administered via a Nebulizer.

    Vectura and Inspira Pharmaceuticals announced a partnership in May 2021 to develop an inhalation-based COVID-19 treatment. Vectura will use its FOX vibrating wire nebulizer to test the IPX formulation’s delivery to the lungs.

    The market for respiratory devices and nebulizers is mature. Due to its low cost, the jet segment dominates the market.

    Other nebulization products will likely face high competition. It is difficult for new technology and devices to gain momentum in mature markets due to the complexity of national regulatory systems and reimbursements that must be followed for both drugs and devices.

    Regional Analysis

    North America accounted for the highest revenue share, at over 31%, in 2021. This is due to the growing number of respiratory diseases and government efforts such as favorable reimbursement scenarios, customer awareness, and a well-established healthcare infrastructure.

    This region will see a rise in demand for technologically advanced products and favorable reimbursement policies. A rise in the U.S. geriatric population is leading to an increase in the number of surgeries, which further increases the region’s market growth.

    In the next 40 years, Americans 65 years and older will double, with 80 million expected to be in 2040.

    The Asia Pacific will be the fastest-growing regional market during the forecast period. This is due to the large geriatric population and increased focus on preventive health care.

    Government initiatives to promote technological innovation are also contributing to this growth.

    These devices are in high demand due to a rise in healthcare spending and increased patient awareness. This market has been attracted to by foreign players because of the low-cost manufacturing locations and favorable taxation policies.

    The region’s market has also seen a rise in medical tourism to countries like India, Malaysia, Singapore, and the Philippines.

    nebulizer market value regional share 2

    Key Regions and Countries covered іn thе rероrt:

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Russia
      • Spain
      • Rest of Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • MEA
      • GCC
      • South Africa
      • Israel
      • Rest of MEA

    Market Share & Key Players Analysis:

    Due to the present major players, the market for nebulizers has matured. The introduction of mesh nebulizers that are technologically advanced has opened up many new opportunities for companies like Vectura Group or PARI Pharma.

    Mesh nebulizers are being used by many pharmaceutical companies for drug development. According to the European and American clinical trial databases, the mesh is preferred over jet nebulizers for drug development clinical trials.

    Companies are pursuing strategies to differentiate their products from other market players. These include new product development, acquisitions, and collaborations with other players and research institutes. In China, HCmed Innovations Co., Ltd. brought Pulmogine to market in 2020.

    Similarly, OMRON Corporation also announced in January 2020 the opening of ATC-TOKYO in Tokyo.

    Customers can now join the company and find solutions to any manufacturing problems with this center. The following are some of the most prominent players in global nebulizer markets:

    nebulizer market company share analysis 2

    Маrkеt Кеу Рlауеrѕ:

    •  Omron Corporation
    •  GE Healthcare
    •  Koninklijke Philips N.V.
    •  Allied Healthcare
    •  Vectura Group Plc.
    •  PARI Respiratory Equipment, Inc.
    •  Aerogen
    •  DeVilbiss Healthcare LLC
    •  Briggs Healthcare
    •  Beurer GmBH
    •  Other Key Players

     

    For the Nebulizers Market research study, the following years have been considered to estimate the market size:

    AttributeReport Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Share
    Tweet
    Share
    Pin
    0 Shares

    Frequently Asked Questions (FAQ)

    Q: What is the Nebulizer market size in 2021?

    A: The Nebulizer market size is US$ 1,100 million for 2021.

    Q: What is the CAGR for the Nebulizer market?

    A: The Nebulizer market is expected to grow at a CAGR of 7.3% during 2023-2032.

    Q: What are the segments covered in the Nebulizer market report?

    A: Market.US has segmented the Global Nebulizer Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type, market has been segmented into Jet, Mesh, Ultrasonic. By End User, market has been further divided into Hospitals & Clinics, Emergency Centers, and Home Healthcare.

    Q: Who are the key players in the Nebulizer market?

    A: Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Allied Healthcare, Vectura Group Plc., PARI Respiratory Equipment, Inc., Aerogen, DeVilbiss Healthcare LLC, Briggs Healthcare, Beurer GmBH, Other Key Players are the key vendors in the Nebulizer market

    Q: Which region is more attractive for vendors in the Nebulizer market?

    A: North America accounted for the highest Revenue share of 31.1% among the other regions. Therefore, the Nebulizer market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

    Q: What are the key markets for Nebulizer?

    A: Key markets for Nebulizer are India, Malaysia, Singapore, and the Philippines

    Q: Which segment has the largest share in the Nebulizer market?

    A: In the Nebulizer market, vendors should focus on grabbing business opportunities from the Jet nebulizer segment as it accounted for the largest market share in the base year.

    Nebulizers Market
    Nebulizers Market
    Published date: Nov 2021
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    •  Omron Corporation
    •  GE Healthcare
    •  Koninklijke Philips N.V.
    •  Allied Healthcare
    •  Vectura Group Plc.
    •  PARI Respiratory Equipment, Inc.
    •  Aerogen
    •  DeVilbiss Healthcare LLC
    •  Briggs Healthcare
    •  Beurer GmBH
    •  Other Key Players
  • settingsSettings

Related Reports

  • Wedding Dress Market
  • Ignition Interlock Devices Market
  • Palletizing Robots Market
  • Home Generators Market
  • Primary Cementing Equipment Market
  • High Purity Organo Silica Sol Market

Our Clients

  • Our Clients
Inquiry Before Buying

Nebulizers Market
  • 16513
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (65)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.